In contrast, genetically modified mice with conditional liver-specific inhibition of Smo, were protected from liver injury and liver fibrosis in different dietary models of NASH, despite similar accumulation of ectopic fat in the liver [37,69]. This evidence concerns the gene SMO and metabolic dysfunction-associated steatohepatitis.